Henry Schein Inc.
08/04/2026 | Press release | Distributed by Public on 08/04/2026 04:14
Business/Financial Results (Form 8-K)
-1-
more
FOR IMMEDIATE RELEASE
HENRY SCHEIN REPORTS STRONGSECOND QUARTER 2026 FINANCIAL RESULTS
AND RAISES FY2026 GUIDANCE
●
Q2 2026 GAAP diluted EPS of $0.82 compared to $0.70 GAAP diluted EPS in Q2 2025
●
Q2 2026 non-GAAP diluted EPS of $1.27 compared to $1.10 non-GAAP diluted EPS in Q2 2025
●
Raises guidance for 2026 to the following: non-GAAP diluted EPS to $5.29 to $5.39, Adjusted EBITDA growth
to mid to high-single digits, and sales growth to 4.5% to 5.5%
MELVILLE,N.Y.,August 4, 2026 -
Henry Schein, Inc. (Nasdaq: HSIC), the world's largestprovider of healthcare
solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June
27, 2026.
"We deliveredstrong sales performance and margin improvement in the second quarter,driven by sustained
momentum across our businesses and solid operational execution by the team. Internal local currency sales growth
accelerated compared to the first quarter, which, combined with strong gross marginsand the early benefits from our value
creation initiatives, drove strong earnings growth," said Fred Lowery,Chief Executive Officer of Henry Schein. "Our first-
half performance and the sustained momentum have positioned us to raise our FY2026 guidance."
"Our value creation plans remain a top focus for our team, and we are on track to achieve our goals. As we sharpen
our focus, our priorities ahead are accelerating growth, simplifying our business, driving operational rigor,and further
deepening our customer relationships,all of which we believe will create sustainable shareholder value," Mr.Lowery added.
Second Quarter 2026 Financial Results
●
Totalnet sales
for the quarter were $3.5 billion, an increase of 6.7% compared to the second quarter of 2025 and
reflects 4.6% internal sales growth, 0.7% sales growth from acquisitions, and a 1.4% increase resulting from foreign
currency exchange. Second quarter sales growth is detailed in Exhibit A
1
.
●
Global Distribution and Value-Added Services sales
for the quarter increased 6.6%, and reflects 4.5% internal
sales growth, 0.6% sales growth from acquisitions, and a 1.5% increase resulting from foreign currency exchange
compared with the second quarter of 2025. The main components are:
●
Global Dental Distribution merchandise sales
for the quarter increased 9.7%, and by 5.9% internal sales
growth, compared with the second quarter of 2025.
●
Global Dental Distribution equipment sales
for the quarter increased 3.8%, and by 2.2% internal sales
growth, compared with the second quarter of 2025.
-2-
more
●
Global Medical Distribution sales
for the quarter increased 4.0%, and by 3.9% internal sales growth,
compared with the second quarter of 2025.
●
Global Value-Added Services sales
for the
quarter increased 5.1%, and by 3.7% internal sales growth,
compared with the second quarter of 2025.
●
Global Specialty Products sales
for the quarter increased 8.7%, and reflects 3.2% internal sales growth, 3.4% sales
growth from acquisitions, and a 2.1% increase resulting from foreign currency exchange, compared with the second
quarter of 2025.
●
Global Technologysales
for the quarter increased 8.2%, and reflects 9.1% internal sales growth,1.3% sales decrease
due to a business disposal, and a 0.4% increase resulting from foreign currency exchange, compared with the second
quarter of 2025.
●
GAAP net income
2
for the quarter was $94 million, or $0.82 per diluted share
4
, and compares with second-quarter
2025 GAAP net income of $86 million, or $0.70 per diluted share.
●
Non-GAAP net income
2
for the quarter was $145 million, or $1.27
per diluted share
4
, and compares with second-
quarter 2025 non-GAAP net income of $135 million, or $1.10 per diluted share.
●
Adjusted EBITDA
3
for the quarter was $288 million and compares with second-quarter 2025 Adjusted EBITDA of
$256 million.
Year-to-Date Financial Results
●
Totalnet sales
for the first half of 2026 were $6.8 billion, an increase of 6.5% compared to the first half of 2025 and
reflects 3.6% internal sales growth, 0.7% sales growth from acquisitions, and a 2.2% increase resulting from foreign
currency exchange. Year-to-date sales growth is detailed in Exhibit A
1
.
●
GAAP net income
2
for the first half of 2026 was $201 million, or $1.74 per diluted share
4
, and compares with
GAAP net income for the first half of 2025 of $196 million, or $1.58 per diluted share.
●
Non-GAAP net income
2
for the first half of 2026 was $298 million, or $2.59
per diluted share
4
, and compares with
non-GAAP net income for the first half of 2025 of $278 million, or $2.25 per diluted share.
●
Adjusted EBITDA
3
for the first half of 2026 was $577 million, and compares with Adjusted EBITDA for the first
half of 2025 of $515 million.
Share Repurchases
During the second quarter of 2026, the Company repurchased approximately 2.6 million shares of common stock at
an average price of $76.69 per share for a total of $200 million.
For the year-to-date, the Company repurchased approximately 4.2 million shares of common stock at an average
price of $77.05 per share for a total of $325 million.
At the end of the quarter, Henry Schein had $455 million authorized and available forfuture stock repurchases.
-3-
more
2026 Financial Guidance
Henry Schein today raised its financial guidance for 2026. Guidance is for current continuing operations and does not
include the impact of restructuring expenses and related costs, amortization expense of acquired intangible assets, the
impairment of intangible assets, changes in contingent consideration, select implementation-related costs supporting value
creation initiatives, and litigation settlements. This guidance also assumes that foreign currency exchange rates remain
generally consistent with current levels.
The Company's FY2026 guidance does not include anyremeasurement gains for the remainder of 2026, or any
future benefits from tariff refunds.In summary, the change in financial guidance is as follows:
Updated
Guidance
Prior
Guidance
2026 non-GAAP diluted EPS
4
$5.29 to $5.39
$5.23 to $5.37
2026 total sales growth
4.5% to 5.5%
3% to 5%
2026 Adjusted EBITDA growth
Mid to high-
single-digits
Mid-single-digits
Adjustments to 2026 GAAP Net Income and Diluted EPS
The Company is providing guidance for 2026 diluted EPS and for 2026 Adjusted EBITDA on a non-GAAP basis, as
noted above. The Company is not providing a reconciliation of its 2026 non-GAAP diluted EPS guidance to its projected
2026 diluted EPS prepared on a GAAP basis, or its 2026 Adjusted EBITDA guidance to net income prepared on a GAAP
basis. This is because the Company is unable to provide without unreasonable effort an estimate of restructuring expenses
and related or similar costs, including its ongoing value creation initiatives, and the corresponding tax effect, which willbe
included in the Company's 2026 diluted EPS andnet income, prepared on a GAAP basis. The inability to provide this
reconciliation is due to the uncertainty and inherent difficulty of predicting the occurrence, magnitude,financial impact and
timing of related costs.
Management does not believe these items are representative of the Company'sunderlying business performance. For
the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be
material to future results.
Second-Quarter 2026 Conference Call Webcast
The Company will hold a conference call to discuss second-quarter 2026 financial results today,beginning at 8:00
a.m. Eastern time. Individual investors are invited to listen to the conference call through Henry Schein'swebsite by visiting
https://investor.henryschein.com/webcasts. In addition,a replay will be available beginning shortly after the call has ended
for a period of one week.
-4-
more
The Company will be posting slides that provide a summary of its second-quarter 2026 financial results on its
website at https://investor.henryschein.com/financials/quarterly-results/
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare
customers.With more than 25,000 TeamSchein Members worldwide, the Company's network of trusted advisors provides
more than 1 million customers globally with more than 300 valued solutions that help improve operational success and
clinical outcomes. Our Business, Clinical, Technologyand Supply Chain solutions help office-based dental and medical
practitioners work more efficiently so they can provide quality care more effectively.These solutions also support dental
laboratories, government and institutional healthcare clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than
300,000 branded products and Henry Schein corporate brand products in our main distribution centers.
A FORTUNE 500 Company and a member of the S&P 500®index, Henry Schein is headquartered in Melville,
N.Y.,and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025,and
have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a publiccompany in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein,
Instagram.com/HenrySchein,and @HenrySchein on X.
Henry Schein Inc. published this content on August 04, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 04, 2026 at 10:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]